ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Powerful Childhood Cancer Treatment Holds Promise–and Poses … – Scientific American

Continue reading

2017-09-12 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 6.4% Above Its 50 Day Average – Finance Daily

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 6.4% Above Its 50 Day AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella a… Continue reading

2017-09-12 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded Over Its 50 Day Moving Average – First News 24

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded Over Its 50 Day Moving AverageFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella … Continue reading

2017-09-12 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 6.4% Above Its 50 Day Average – Finance Daily

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 6.4% Above Its 50 Day AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella a… Continue reading

2017-09-12 Michael Zand NEWS

New Approach Could Offer a Better Way to Make Stem Cells – Technology Networks

Technology NetworksNew Approach Could Offer a Better Way to Make Stem CellsTechnology NetworksIn a study published in an Advance Online paper in Nature Biotechnology, the TSRI scientists screened a library of 100 million antibodies and found several th… Continue reading

2017-09-12 Michael Zand NEWS

New Approach Could Offer a Better Way to Make Stem Cells – Technology Networks

Technology NetworksNew Approach Could Offer a Better Way to Make Stem CellsTechnology NetworksIn a study published in an Advance Online paper in Nature Biotechnology, the TSRI scientists screened a library of 100 million antibodies and found several th… Continue reading

2017-09-12 Michael Zand NEWS

Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In … – Clinical Leader


Scientific American

Powerful Childhood Cancer Treatment Holds Promise–and Poses …
Scientific American
A new type of cancer therapy—recently approved by the U.S. Food and Drug Administration for children with leukemia who run out of options—is changing …

and more »

Continue reading

2017-09-12 Michael Zand NEWS

CRISPR breakthrough ignites hope of using pigs as organ donors – ScienceNordic

Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In …
Clinical Leader
Plymouth Meeting, PA (GLOBE NEWSWIRE) – Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8+ killer T cell responses …

and more »

Continue reading

2017-09-12 Michael Zand NEWS
  • 1
  • …
  • 1,216
  • 1,217
  • 1,218
  • 1,219
  • 1,220
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

CRISPR breakthrough ignites hope of using pigs as organ donors
ScienceNordic
It is the second problem that scientists have now solved with the gene-editing tool, CRISPR. “We’ve switched off the porcine endogenous retroviruses (PERVs) in the pigs, so that the PERVs can no longer replicate itself and infect people,” says Luo.